Lv1
10 积分 2020-07-30 加入
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
17天前
已完结
Causes and control of excess body fat
18天前
已完结
Efficacy, adherence and persistence of various glucagon‐like peptide‐1 agonists: nationwide real‐life data
21天前
已完结
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
24天前
已完结
Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2)
25天前
已完结
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes
26天前
已完结
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes
1个月前
已完结
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
1个月前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
High-protein diet prevents fat mass increase after dieting by counteracting Lactobacillus-enhanced lipid absorption
2个月前
已完结
皖公网安备34019202002308
